Statement Of Income And Retained Earnings

STELLA PHARMA CORPORATION - Filing #7320249

Concept 2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
Statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
-760,300,000 JPY
-806,775,000 JPY
Non-operating income
Non-operating income
4,624,000 JPY
40,620,000 JPY
Non-operating expenses
Non-operating expenses
4,533,000 JPY
9,818,000 JPY
Ordinary profit (loss)
-760,208,000 JPY
-775,974,000 JPY
Extraordinary losses
Extraordinary losses
768,000 JPY
JPY
Profit (loss) before income taxes
-760,976,000 JPY
-775,974,000 JPY
Income taxes - current
2,772,000 JPY
2,850,000 JPY
Profit (loss)
-763,749,000 JPY
-763,749,000 JPY
-763,749,000 JPY
-763,749,000 JPY
-778,824,000 JPY
-778,824,000 JPY
-778,824,000 JPY
-778,824,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.